Mirum Pharmaceuticals MIRM Q1 2026 Results Miss Estimates EPS 108 vs 036 Avita Medical RCEL Q1 2026 Earnings Miss Sparks Concern Alibabas AI and Cloud Strategy Fuels Market Speculation Defense Sector Transformation How Autonomous Weapons Reshape Investment Landscape Global Markets on Edge as Oil Crisis Spurs Debt Selloff Trump Issues Iran Warning Cerebras Systems IPO Draws Cramers Caution Amid Massive FirstDay Rally Watts WTS Reports Strong Q1 2026 Revenue NA EPS Beats Eutelsat Meets Q3 Revenue Forecasts as LEO Satellite Growth Offsets Video Segment Decline US Lawmakers Push to Block Chinese EVs Raising Cost Concerns for American Buyers Seeking Stability Amid Volatile Fossil Fuel Markets UN Calls for Coordinated Action Geopolitical Tensions Rise as Trump Places Taiwan Arms Sales Hong Kong Activist Case on Xi Summit Agenda